462 related articles for article (PubMed ID: 29878757)
1. Photothermal-Activatable Fe
Ge R; Liu C; Zhang X; Wang W; Li B; Liu J; Liu Y; Sun H; Zhang D; Hou Y; Zhang H; Yang B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20342-20355. PubMed ID: 29878757
[TBL] [Abstract][Full Text] [Related]
2. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
[TBL] [Abstract][Full Text] [Related]
3. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy.
Yasothamani V; Vivek R
J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846
[TBL] [Abstract][Full Text] [Related]
4. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
[TBL] [Abstract][Full Text] [Related]
5. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.
Chen Q; Xu L; Liang C; Wang C; Peng R; Liu Z
Nat Commun; 2016 Oct; 7():13193. PubMed ID: 27767031
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
[TBL] [Abstract][Full Text] [Related]
7. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
[TBL] [Abstract][Full Text] [Related]
8. Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors.
Luo L; Zhu C; Yin H; Jiang M; Zhang J; Qin B; Luo Z; Yuan X; Yang J; Li W; Du Y; You J
ACS Nano; 2018 Aug; 12(8):7647-7662. PubMed ID: 30020768
[TBL] [Abstract][Full Text] [Related]
9. Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy.
Yue J; Mei Q; Wang P; Miao P; Dong WF; Li L
J Nanobiotechnology; 2022 Apr; 20(1):181. PubMed ID: 35392911
[TBL] [Abstract][Full Text] [Related]
10. Immunosonodynamic Therapy Designed with Activatable Sonosensitizer and Immune Stimulant Imiquimod.
Lei H; Kim JH; Son S; Chen L; Pei Z; Yang Y; Liu Z; Cheng L; Kim JS
ACS Nano; 2022 Jul; 16(7):10979-10993. PubMed ID: 35723442
[TBL] [Abstract][Full Text] [Related]
11. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z
J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039
[TBL] [Abstract][Full Text] [Related]
12. Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma.
Lu YF; Zhou JP; Zhou QM; Yang XY; Wang XJ; Yu JN; Zhang JG; Du YZ; Yu RS
J Nanobiotechnology; 2022 Jul; 20(1):351. PubMed ID: 35907841
[TBL] [Abstract][Full Text] [Related]
13. Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy.
Zhang F; Lu G; Wen X; Li F; Ji X; Li Q; Wu M; Cheng Q; Yu Y; Tang J; Mei L
J Control Release; 2020 Oct; 326():131-139. PubMed ID: 32580043
[TBL] [Abstract][Full Text] [Related]
14. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect.
Chen B; Huang R; Zeng W; Wang W; Min Y
Biomaterials; 2024 Mar; 305():122434. PubMed ID: 38141501
[TBL] [Abstract][Full Text] [Related]
15. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.
Takeda Y; Kataoka K; Yamagishi J; Ogawa S; Seya T; Matsumoto M
Cell Rep; 2017 May; 19(9):1874-1887. PubMed ID: 28564605
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
[TBL] [Abstract][Full Text] [Related]
18. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation.
Liang X; Ye X; Wang C; Xing C; Miao Q; Xie Z; Chen X; Zhang X; Zhang H; Mei L
J Control Release; 2019 Feb; 296():150-161. PubMed ID: 30682441
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
[TBL] [Abstract][Full Text] [Related]
20. Precision USPIO-PEG-SLe
Li T; Guo L; Li J; Mu X; Liu L; Song S; Luo N; Zhang Q; Zheng B; Jin G
Int J Nanomedicine; 2024; 19():1249-1272. PubMed ID: 38348177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]